Tetrahydrocannabinol and endocannabinoids in feeding and appetite

被引：144

作者：

Berry, EM

Mechoulam, R ^{[1
]}

机构：

[1] Hebrew Univ Jerusalem, Fac Med, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel

[2] Hebrew Univ Jerusalem, Sch Publ Hlth, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel

来源：

PHARMACOLOGY & THERAPEUTICS | 2002年 / 95卷 / 02期

关键词：

anandamide; 2-arachidonoylglycerol; leptin; SR141716A; suckling; cannabinoid receptors;

D O I：

10.1016/S0163-7258(02)00257-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The physiological control of appetite and satiety, in which numerous neurotransmitters and neuropeptides play a role, is extremely complex. Here we describe the involvement of endocannabinoids in these processes. These endogenous neuromodulators enhance appetite in animals. The same effect is observed in animals and in humans with the psychotropic plant cannabinoid Delta(9)-tetrahydrocannabinol, which is an approved appetite-enhancing drug. The CB1 cannabinoid receptor antagonist SR141716A blocks the effects on feeding produced by the endocannabinoids. If administered to mice pups, this antagonist blocks suckling, In obese humans, it causes weight reduction. Very little is known about the physiological and biochemical mechanisms involved in the effects of Delta(9)-tetrahydrocannabinol and the cannabinoids in feeding and appetite. (C) 2002 Elsevier Science Inc. All rights reserved.

引用

收藏

页码：185 / 190

页数：6

相关论文

共 63 条

[1] EFFECTS OF MARIHUANA ON SOLUTION OF ANAGRAMS, MEMORY AND APPETITE [J].

ABEL, EL .

NATURE, 1971, 231 (5300) :260-&

[2]

[Anonymous], 1845, DUBLIN J MED SCI, DOI DOI 10.1007/BF02971741

[3] Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors [J].

Arnone, M ;

Maruani, J ;

Chaperon, F ;

Thiebot, MH ;

Poncelet, M ;

Soubrie, P ;

LeFur, G .

PSYCHOPHARMACOLOGY, 1997, 132 (01) :104-106

[4] HIV wasting syndrome: Treatment update [J].

Balog, DL ;

Epstein, ME ;

Amodio-Groton, MI .

ANNALS OF PHARMACOTHERAPY, 1998, 32 (04) :446-458

[5] DRONABINOL AS A TREATMENT FOR ANOREXIA ASSOCIATED WITH WEIGHT-LOSS IN PATIENTS WITH AIDS [J].

BEAL, JE ;

OLSON, R ;

LAUBENSTEIN, L ;

MORALES, JO ;

BELLMAN, P ;

YANGCO, B ;

LEFKOWITZ, L ;

PLASSE, TF ;

SHEPARD, KV .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (02) :89-97

[6] Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia [J].

Beal, JE ;

Olson, R ;

Lefkowitz, L ;

Larenstein, L ;

Bellman, P ;

Yangco, B ;

Morales, JO ;

Murphy, R ;

Powderly, W ;

Plasse, TF ;

Mosdell, KW ;

Shepard, KV .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 14 (01) :7-14

[7] An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity [J].

Ben-Shabat, S ;

Fride, E ;

Sheskin, T ;

Tamiri, T ;

Rhee, MH ;

Vogel, Z ;

Bisogno, T ;

De Petrocellis, L ;

Di Marzo, V ;

Mechoulam, R .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 353 (01) :23-31

[8] Anandamide and diet:: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets [J].

Berger, A ;

Crozier, G ;

Bisogno, T ;

Cavaliere, P ;

Innis, S ;

Di Marzo, V .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) :6402-6406

[9] Disorders of eating in the elderly [J].

Berry, EM ;

Marcus, EL .

JOURNAL OF ADULT DEVELOPMENT, 2000, 7 (02) :87-99

[10]

BIRCH EA, 1889, LANCET, V1, P625

← 1 2 3 4 5 6 7 →